This article applies specifically to the Enclomiphene treatment plan.

Requirements may differ for other Maximus programs. Blood flow medications referenced in this article are also explained in the Blood Flow Protocol articles.
​
Some Enclomiphene treatment plans may combine Enclomiphene with medications that support blood flow, such as Tadalafil or Vardenafil, into a single daily tablet.

This approach is designed to support both:

Your clinician determines whether a combination approach is appropriate based on your health profile, treatment goals, and current medications.

These combinations may be available for both new and existing Enclomiphene patients.

Each medication in the combination supports a different physiological pathway.

Supports the body’s natural testosterone production by influencing hormonal signaling involved in testosterone regulation.

Supports circulation by helping blood vessels relax, which may improve blood flow throughout the body.

Works through similar vascular pathways to support circulation and erectile function.

Together, these medications may help support both hormonal balance and blood flow, which are two key factors involved in sexual performance.

Combination treatments are typically taken:

Your clinician determines the appropriate medication strengths and treatment plan.

Your clinician may consider combination therapy for individuals who:

Availability may vary by patient eligibility and clinician evaluation.

Currently, this treatment option is available for men only.

Combination therapies may be used alongside certain other hormone-based treatments depending on clinician evaluation.

Your clinician will determine whether combining protocols is appropriate based on your health profile and treatment goals.

If you are currently using a separate Blood Flow protocol, your clinician may recommend discontinuing that protocol if switching to a combined treatment option.

Combination treatments are not appropriate for everyone.

Before prescribing, your clinician evaluates factors such as:

Certain medications and health conditions may prevent the use of PDE-5 inhibitors.

Your clinician will determine whether the treatment is safe and appropriate for you.

Your clinician monitors your treatment through:

If adjustments are needed, your clinician can review options with you.

If you have questions about:

you can message your clinician through your patient portal or contact Support for assistance with account-related questions.